BeriCos® PAD : The Gentle Multifunctional Skincare Hero

Meet BeriCos® PAD (Potassium Azeloyl Diglycinate), the advanced water-soluble derivative of azelaic acid that redefines mild yet high-performance skincare. Crafted by combining azelaic acid with glycine in potassium salt form, it solves traditional azelaic acid’s biggest pain points—poor solubility and irritation—while amplifying its core benefits. This innovative active delivers triple-action efficacy: brightening, anti-acne, and soothing, making it a must-have for modern skincare formulations.



Product Name: BeriCos® PAD

INCI Name：Potassium Azeloyl Diglycinate

Appearance: White to off-white powder

Solubility: Water-soluble

Molecular Weight: 342.43

EINECS: 686-756-8

CAS No.: 477773-67-4

Molecular Formula: C₁₃H₂₃KN₂O₆

Purity： ≥99%


Unmatched Brightening & Anti-Pigmentation Power

BeriCos® PAD Potassium Azeloyl Diglycinate competitively inhibits tyrosinase, the key enzyme driving melanin synthesis (IC₅₀=12.4μM, stronger than arbutin). It also downregulates MITF protein and blocks melanosome transfer, effectively fading dark spots, post-acne marks, and uneven tone for a radiant, porcelain-like complexion.



Oil Control & Anti-Acne Excellence

Ideal for oily and acne-prone skin, it suppresses Cutibacterium acnes (MIC=32μg/mL) to reduce inflammation and breakouts. By inhibiting 5α-reductase, it regulates sebum production, minimizes pores, and prevents blackheads—all without over-drying the skin.



Gentle Soothing & Hydration

Thanks to its glycine moiety, BeriCos® PAD Potassium Azeloyl Diglycinate provides instant hydration and strengthens the skin barrier. It calms redness and irritation, making it perfect for sensitive skin—a stark contrast to harsh azelaic acid. Stable across pH 4–8.5, it’s easy to formulate into toners, serums, creams, and masks with an addition rate of 1.0–3.5% for leave-on products.



Why Choose BeriCos® PADPotassium Azeloyl Diglycinate ?


  1. 100% water-soluble: No solubility issues, compatible with all aqueous formulations.

  2. Low irritation: Safe for long-term use on sensitive, acne-prone, or post-procedure skin.

  3. Synergistic potential: Pairs perfectly with niacinamide, tranexamic acid, and panthenol for enhanced results.

  4. Proven stability: Heat-resistant (decomposition at 235°C) and long-lasting in formulations.


Elevate your skincare line with BeriCos® PAD Potassium Azeloyl Diglycinate —the gentle yet potent active that brightens, purifies, and soothes, delivering healthy, glowing skin for all.


Elena@zhberi.com

Comments

Post a Comment

Popular posts from this blog

NMPA Registed Pterostilbene - Beri Pharma Co., Ltd

Image
  NMPA Registed  Pterostilbene Pterostilbene is a dimethyl derivative of resveratrol, and its stability is significantly better than that of resveratrol, which is not included in the "Catalogue of Used Cosmetic Raw Materials (2021 Edition)", and is expected to become an upgraded alternative to resveratrol after being developed as a new cosmetic raw material, with high development value. 1. Whitening effect: inhibits tyrosinase activity 2. Anti-wrinkle and skin elasticity enhancement effect 3. Inhibits collagenase and elastase activities and enhances collagen secretion. 4. Protects against ultraviolet rays and enhances sun protection 5. Anti-inflammatory effect 6. Anti-glycation effects Beri Pharma Co., Ltd Beri Pharma Co., Ltd. - New NMPA registered Pterostilbene (google.com)
Read more

Hexylresorcinol Supplier - Beri Pharma - Hexyl Resorcinol (Cas 136-77-6)

Image
BeriCos® HR   Hexyl Resorcinol  Product name： Hexylresorcinol （HR） chemical Name: 4-Hexyl-1,3-benzenediol INCI: Hexylresorcinol Molecular weight: 194.27 Molecular formula: C12H18O2 CAS No.: 136-77-6 Application guidance Security Data & Laws and Regulations • Europe: Permitted in personal care products • USA：Permitted in personal care products • Japan：Permitted in personal care products • China：Permitted in personal care products Acute toxicity： • Rat Oral LD50：550mg/kg； • Mice transoral LD50:1040mg/kg； • Mouse abdominal cavity LD50：335mg/kg； • Mouse subcutaneous LDLo：750mg/kg； • Mouse pathway unknown LDLo：100mg/kg； • Guinea pig transoral LDLo：440mg/kg； Additional multi-dose data： • Oral TDLo of rats: 16250mg/kg/13W-I; • Mice transoral TDLo: 32500mg/kg/13W-I; • Tumorigenic data: Mice transoral TDLo:  64mg/kg/2Y-C; • Reproductive data: Subcutaneous exposure to TDLo 1 day before mating: 5mg/kg; • Mutagenicity data: Bacteria-E. coli DNA repair  system:...
Read more